Horizon Therapeutics Public Limited Company 8-K Jan. 24, 2018 4:07 PM
FORM 8-K | Current report Horizon Pharma plc (Form: 8-K, Received: 01/24/2018 16:07:46) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C.
Name: Dave A. Happel
Continent: Europe
Country: Ireland
Company: Horizon Pharma plc
Branch: Pharma
Position: VP
Reason: Resigned
Announcement Date: January 17, 2018, 11:00pm
Resignation Date: January 17, 2018, 11:00pm
Source 1: https://seekingalpha.com/filing/3842648